UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: August 24, 2022
Accession Number:
Submission Type:
CIK: 0001766140
Company Name: Unicycive Therapeutics, Inc.
File Number: 333-266890